Transforming commercial pharma with agentic AI

MIT Technology Review 

From sales to compliance, AI agents promise to augment workforce capabilities, streamline workflows, and enhance productivity. Amid the turbulence of the wider global economy in recent years, the pharmaceuticals industry is weathering its own storms. Simultaneously, the cost of bringing new drugs to market is climbing. In clinics and health-care facilities, norms and expectations are evolving, too. Patients and health-care providers are seeking more personalized services, leading to greater demand for precision drugs and targeted therapies. The need for personalization extends to sales and marketing operations too as pharma companies are increasingly needing to compete for the attention of health-care professionals (HCPs).